Renal Cancer - Results from #2400

Randomized trial assessing impact of probiotic supplementation on gut microbiome and clinical outcome from targeted therapy in metastatic renal cell carcinoma. November 5, 2020

Evolving Paradigms in the Management and Outcomes of Sarcomatoid Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors. November 4, 2020

CTLA4 has a profound impact on the landscape of tumor-infiltrating lymphocytes with a high prognosis value in clear cell renal cell carcinoma (ccRCC). November 4, 2020

Current updates and future perspectives on the management of renal cell carcinoma. November 4, 2020

Combination of Hematology Indicators and Oncological Characteristics as a New Promising Prognostic Factor in Localized Clear Cell Renal Cell Carcinoma. November 4, 2020

Is partial nephrectomy safe and effective in the setting of frail comorbid patients affected by renal cell carcinoma? Insights from the RECORD 2 multicentre prospective study. November 3, 2020

KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer. November 3, 2020

Optimized Combination of HDACI and TKI Efficiently Inhibits Metabolic Activity in Renal Cell Carcinoma and Overcomes Sunitinib Resistance. November 3, 2020

BRDT is a novel regulator of eIF4EBP1 in renal cell carcinoma. November 2, 2020

The impact of intraoperative bleeding on the risk of chronic kidney disease after nephron-sparing surgery. November 2, 2020

Endocytosis-mediated replenishment of amino acids favors cancer cell proliferation and survival in chromophobe renal cell carcinoma. November 2, 2020

circ_001504 promotes the development of renal cell carcinoma by sponging microRNA-149 to increase NUCB2. October 30, 2020

Long non-coding RNAs and renal cell carcinoma. October 30, 2020

Genetic Analysis Identifies the Role of HLF in Renal Cell Carcinoma. October 30, 2020

Efficacy and Safety of Axitinib Therapy After Nivolumab for Patients With Metastatic Renal Cell Cancer. October 29, 2020

The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery-Results from RECUR Consortium. October 29, 2020

Stereotactic radiotherapy combined with immune- or targeted therapy for metastatic renal cell carcinoma. October 29, 2020

Prognostic Value of YTHDF2 in Clear Cell Renal Cell Carcinoma. October 28, 2020

Organotypic primary blood vessel models of clear cell renal cell carcinoma for single-patient clinical trials. October 28, 2020

Differentiation of renal cell tumors with morphological cocktails using a minimal panel of immunohistochemical markers. October 28, 2020

Page 121 of 456